Third Arc Bio is paying $5 million upfront to use Adagene’s tech in hopes of creating two new masked T-cell engagers. Down the line, Adagene could make up to $840 million in development and commercial ...

As we age, the muscles we rely on for daily activities tend to become less reliable. With enough decline, even normal ...

A study from the Weizmann Institute of Science’s Immunotherapy Research Center released this week highlights the discovery of a new class of immune-activating molecules that could help the body’s ...

A single base change can create a devastating genetic disorder or a beneficial adaptation, or it might have no effect. How do mutations happen, and how do they influence the future of a species?